Your browser doesn't support javascript.
loading
Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy.
Louis, Renaud; Harrison, Tim W; Chanez, Pascal; Menzella, Francesco; Philteos, George; Cosio, Borja G; Lugogo, Njira L; de Luiz, Gustavo; Burden, Annie; Adlington, Timothy; Keeling, Nanna; Kwiatek, Justin; Garcia Gil, Esther.
Affiliation
  • Louis R; Department of Pneumology CHU Liége, GIGAI3, University of Liége, Liége, Belgium.
  • Harrison TW; Respiratory Research Unit, Nottingham Respiratory NIHR BRC, University of Nottingham, Nottingham, UK; Global Medical Affairs, AstraZeneca, Cambridge, UK. Electronic address: Tim.Harrison@nottingham.ac.uk.
  • Chanez P; Department of Respiratory CIC Nord INSERMINRAE C2VN, Aix Marseille University, Marseille, France.
  • Menzella F; Pulmonology Unit, S. Valentino Hospital, Local Health Authority, Montebelluna, Italy.
  • Philteos G; Royal University Hospital, University of Saskatchewan, Saskatoon, Sask, Canada.
  • Cosio BG; Hospital Son Espases-IdISBa and Ciberes, Palma de Mallorca, Spain.
  • Lugogo NL; University of Michigan, Ann Arbor, Mich.
  • de Luiz G; Clinical Research and Respiratory Medicine Department, Vithas Xanit International Hospital, Benalmadena, Málaga, Spain.
  • Burden A; Biometrics, Late-stage Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Adlington T; Biometrics, Late-stage Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Keeling N; BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden.
  • Kwiatek J; BioPharmaceuticals Medical, AstraZeneca, Wilmington, Del.
  • Garcia Gil E; BioPharmaceuticals Medical, AstraZeneca, Barcelona, Spain.
J Allergy Clin Immunol Pract ; 11(6): 1759-1770.e7, 2023 06.
Article de En | MEDLINE | ID: mdl-36948488

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Asthme / Antiasthmatiques Type d'étude: Clinical_trials / Guideline Limites: Adult / Humans Langue: En Journal: J Allergy Clin Immunol Pract Année: 2023 Type de document: Article Pays d'affiliation: Belgique Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Asthme / Antiasthmatiques Type d'étude: Clinical_trials / Guideline Limites: Adult / Humans Langue: En Journal: J Allergy Clin Immunol Pract Année: 2023 Type de document: Article Pays d'affiliation: Belgique Pays de publication: États-Unis d'Amérique